Seeing eye to eye with gene therapy.
作者信息
Herzog Roland W
出版信息
Mol Ther. 2012 Apr;20(4):687-8. doi: 10.1038/mt.2012.43.
Abstract
摘要
相似文献
1
Seeing eye to eye with gene therapy.对基因治疗达成一致看法。
Mol Ther. 2012 Apr;20(4):687-8. doi: 10.1038/mt.2012.43.
2
Gene Therapy for Blinding Pediatric Eye Disorders.用于致盲性小儿眼部疾病的基因治疗
Adv Pediatr. 2015 Aug;62(1):185-210. doi: 10.1016/j.yapd.2015.04.012.
3
Ocular Gene Therapy-The Future Is Now.
Asia Pac J Ophthalmol (Phila). 2016 Jul-Aug;5(4):227-8. doi: 10.1097/APO.0000000000000216.
4
Gene therapy: new "magic bullets" to prevent ocular scarring.基因疗法：预防眼部瘢痕形成的新型“神奇子弹”
Br J Ophthalmol. 2002 May;86(5):490-2. doi: 10.1136/bjo.86.5.490.
5
Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.用于将治疗性基因递送至眼组织的单纯疱疹病毒载体。眼部疾病分子遗传学的最新突破。
Invest Ophthalmol Vis Sci. 1994 May;35(6):2662-6.
6
Do Genes Matter in Treating Eye Disease?
Ocul Surf. 2015 Oct;13(4):346-9. doi: 10.1016/j.jtos.2015.08.003. Epub 2015 Aug 10.
7
[Ophthalmogenetics: Rare Diseases - A Challenge for Diagnostic and Treatment].[眼科遗传学：罕见疾病——诊断与治疗的挑战]
Klin Monbl Augenheilkd. 2016 Mar;232(3):242. doi: 10.1055/s-0041-109518. Epub 2016 Mar 24.
8
[Molecular genetics: significance in hereditary eye diseases].[分子遗传学：在遗传性眼病中的意义]
Klin Monbl Augenheilkd. 2014 Mar;231(3):208-9. doi: 10.1055/s-0033-1360401. Epub 2014 Mar 21.
9
Harnessing the Power of Genetic Engineering for Patients With Mitochondrial Eye Diseases.利用基因工程的力量治疗线粒体眼病患者。
J Neuroophthalmol. 2017 Mar;37(1):56-64. doi: 10.1097/WNO.0000000000000476.
10
Eyes on New Product Development.关注新产品开发。
J Ocul Pharmacol Ther. 2015 Sep;31(7):363-4. doi: 10.1089/jop.2015.29002.gdn. Epub 2015 Aug 11.
引用本文的文献
1
A new vision of mesenchymal stromal cells.间充质基质细胞的新视野。
Mol Ther. 2012 Nov;20(11):2017-8. doi: 10.1038/mt.2012.221.
本文引用的文献
1
AAV2 gene therapy readministration in three adults with congenital blindness.三种成人先天性失明患者接受 AAV2 基因治疗再给药。
Sci Transl Med. 2012 Feb 8;4(120):120ra15. doi: 10.1126/scitranslmed.3002865.
2
Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma.眼内注射腺病毒载体后儿童体内无全身免疫反应。
Mol Ther. 2010 Oct;18(10):1885-90. doi: 10.1038/mt.2010.139. Epub 2010 Jul 6.
Zotero 插件